RACHAEL FORNWALT: Open Payments
NPI 1750774691 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 35 payments from 23 companies in 2025. Trend: 2023 $101 · 2024 $307 · 2025 $986
Food & beverage: $886Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $188 |
| SOBI, INC | 2 | $130 |
| Eisai Inc. | 2 | $60 |
| Incyte Corporation | 3 | $59 |
| Acrotech Biopharma Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| GENZYME CORPORATION | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Celgene Corporation | 2 | $33 |
Products named: Enhertu, Lenvima, JAKAFI, BELEODAQ, SARCLISA, ICLUSIG, LIBTAYO, REBLOZYL.
Industry payments across PA — which companies pay providers there.
